Clinical trials of hydroxychloroquine in COVID19 outpatients are safe

Clinical trials of hydroxychloroquine in COVID-19 outpatients are safe

• Download PDF Copy

By Dr. Liji Thomas, MDJul 27 2020Reviewed by Emily Henderson, B.Sc.

According to new research published in the preprint server medRxiv* in July 2020, the use of hydroxychloroquine (HCQ) among outpatients in clinical trials, without high-risk factors for cardiac arrhythmia, is safe, with gastrointestinal side-effects being the most common side effects and no fatal adverse outcomes.